Acasti Pharma (NASDAQ: ACST)
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-11 | ||||||
REV |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.100 | -0.040 | 0.0600 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Acasti Pharma (NASDAQ: ACST) through any online brokerage.
There are no as such competitors for Acasti Pharma.
The latest price target for Acasti Pharma (NASDAQ: ACST) was reported by Oppenheimer on Wednesday, December 22, 2021. The analyst firm set a price target for 6.00 expecting ACST to rise to within 12 months (a possible 603.81% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Acasti Pharma (NASDAQ: ACST) is $0.8525 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Acasti Pharma.
Acasti Pharma’s Q1 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for Acasti Pharma.
Acasti Pharma is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.